Track Bluejay Diagnostics Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Bluejay Diagnostics Inc. Common Stock BJDX · Stock Open Bluejay Diagnostics Inc. Common Stock in new tab

0.8461 USD
Add to portfolio
P/E
0.00
EPS
-2.27
P/B
0.19
ROE
-98.89
Beta
0.91
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateNov. 13, 2026
P/E0.00
EPS-2.27
Book Value4.75
Price to Book0.19
Debt/Equity0.86
% Insiders2.032%
Estimates
Forward P/E-2.88
Forward EPS-0.32

DCF Valuation

Tweak assumptions to recompute fair value for Bluejay Diagnostics Inc. Common Stock (BJDX)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Bluejay Diagnostics Inc. Common Stock Logo Bluejay Diagnostics Inc. Common Stock Analysis (BJDX)

United States Health Care Official Website Stock

Is Bluejay Diagnostics Inc. Common Stock a good investment? Bluejay Diagnostics Inc. Common Stock (BJDX) is currently trading at 0.8461 USD.

In terms of valuation, the stock trades at a P/E ratio of 0.00. This relatively low multiple may signal that Bluejay Diagnostics Inc. Common Stock is undervalued compared to historical market norms.

Earnings Schedule: Bluejay Diagnostics Inc. Common Stock is expected to release its next earnings report on Nov. 13, 2026. The market consensus estimate for Forward EPS is -0.32.

Investor FAQ

Does Bluejay Diagnostics Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Bluejay Diagnostics Inc. Common Stock?

Bluejay Diagnostics Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Nov. 13, 2026. The company currently has a trailing EPS of -2.27.

Company Profile

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Exchange Ticker
NMS (United States) BJDX
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
July 24, 2023 1:20
June 20, 2024 Needs review
Nov. 18, 2024 1:50
Jan. 29, 2026 1:4
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion